Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Design, Synthesis, and Biological Evaluation of 2,4-Dihydropyrano[2,3-c]pyrazole Derivatives as Autotaxin Inhibitors

Thumbnail
Files
Article (529.6Kb)
Self archived version
final draft
Date
2017
Author(s)
Pantsar T
Singha P
Nevalainen TJ
Koshevoy I
Leppänen J
Poso A
Niskanen JMA
Pasonen-Seppänen S
Savinainen JR
Laitinen T
Laitinen JT
Unique identifier
10.1016/j.ejps.2017.07.002
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Pantsar T. Singha P. Nevalainen TJ. Koshevoy I. Leppänen J. Poso A. Niskanen JMA. Pasonen-Seppänen S. Savinainen JR. Laitinen T. Laitinen JT. (2017). Design, Synthesis, and Biological Evaluation of 2,4-Dihydropyrano[2,3-c]pyrazole Derivatives as Autotaxin Inhibitors.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 107, 97-111. 10.1016/j.ejps.2017.07.002.
Rights
© Elsevier B.V
Licensed under
CC BY-NC-ND https://creativecommons.org/licenses/by-nc-nd/4.0/
Abstract

Inhibition of Autotaxin (ATX) is a potential treatment strategy for several diseases, including tumors with elevated ATX-lysophosphatidic acid (LPA) signaling. Combining structure-based virtual screening together with hen egg-white Autotaxin (ewATX) activity assays enabled the discovery of novel small-molecule ATX inhibitors with a 2,4-dihydropyrano[2,3-c]pyrazole scaffold. These compounds are suggested to bind to the lipophilic pocket, leaving the active site unrestrained. Our most potent compound, (S)-6-amino-4-(3,4-dichlorophenyl)-3-(4-[(4-fluorobenzyl)oxy]phenyl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile [(S)-25], inhibited human ATX (hATX) with an IC50-value of 134 nM. It also blocked ATX-evoked but not LPA-mediated A2058 melanoma cell migration. Noteworthy, molecular modeling correctly predicted the biologically active enantiomer of 2,4-dihydropyrano[2,3-c]pyrazoles, as verified by compound crystallization and activity assays. Our study established the ewATX activity assay as a valid and affordable tool in ATX inhibitor discovery. Overall, our study offers novel insights and approaches into design of novel ATX inhibitors targeting the hydrophobic pocket instead of the active site.

Subjects
Virtual screening   Molecular modeling   Chirality   Dihydropyrano[2,3-c]pyrazole   ENPP2   Cancer   
URI
https://erepo.uef.fi/handle/123456789/4402
Link to the original item
http://dx.doi.org/10.1016/j.ejps.2017.07.002
Publisher
Elsevier BV
Collections
  • Terveystieteiden tiedekunta [1281]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap